Patents by Inventor Céline BERTAUX

Céline BERTAUX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunocytokines for the treatment of cancer
    Patent number: 11673931
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Grant
    Filed: April 1, 2020
    Date of Patent: June 13, 2023
    Assignee: PIERRE FABRE MEDICAMENT
    Inventors: Peter Lowe, Jean-François Haeuw, Alicia Contet, Céline Bertaux, Barbara Akla, Marie-Claire Janin-Bussat, Martine Malissard, Juliette Trepreau
  • NEW IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
    Publication number: 20220048966
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Application
    Filed: September 30, 2019
    Publication date: February 17, 2022
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Peter LOWE, Jean-François HAEUW, Alicia CONTET, Céline BERTAUX, Barbara AKLA, Marie-Claire JANIN-BUSSAT
  • IMMUNOCYTOKINES FOR THE TREATMENT OF CANCER
    Publication number: 20200308242
    Abstract: The present invention relates to new immunocytokines which are useful for the treatment of cancer. These fusion proteins comprise (i) an antibody or antigen-binding fragment thereof fused to (ii) a cleavable peptide linker, and (iii) cytokine, or functional fragments thereof. Methods of treatment using these immunocytokines are also disclosed.
    Type: Application
    Filed: April 1, 2020
    Publication date: October 1, 2020
    Applicant: PIERRE FABRE MEDICAMENT
    Inventors: Peter LOWE, Jean-François HAEUW, Alicia CONTET, Céline BERTAUX, Barbara AKLA, Marie-Claire JANIN-BUSSAT